Rethinking scientific responsibility by Forssén, Annika et al.
Rethinking scientiﬁc responsibility
Annika Forsse ´n,
1 Eivind Meland,
2 Irene Hetlevik,
3 Roger Strand
4
ABSTRACT
Researchers should be made co-responsible for the
wider consequences of their research focus and the
application of their ﬁndings. This paper describes
a meta-reﬂection procedure that can be used as a tool to
enhance scientiﬁc responsibility and reﬂective practice.
The point of departure is that scientiﬁc practice is
situated in power relations, has direction and,
consequently, power implications. The contextual
preconditions and implications of research should be
stated and discussed openly. The reﬂection method aims
at revealing both upstream elements, such as for
instance preconceptions, and downstream elements, for
example, public consequences of research. The validity
of research might improve from such discussions.
Validity should preferably be understood as a broader
concept than the methodological concerns in science.
As general practitioners (GPs) (AF, EM, IH) and
researchers, we are active participants in medical
development, leading us to reﬂect on the scientiﬁc
knowledge needed and produced. Many GPs are
also concerned about sustainable and responsible
medicine, particularly in the light of the increased
research focus on risks and the escalating demands
for medical prevention.
1 2 However, the medical
scientiﬁc community seems to regard itself as
largely detached from society, merely supplying
users with disinterested information.
34Within the
scholarly ﬁelds studying the relationships between
science, technology and society, this dissociative
view of value-neutral science and value-laden use
was rejected on empirical and theoretical grounds
decades ago.
5 The acknowledgement that scientiﬁc
practice is value-laden, uncertain, open-ended and
embedded in complex contexts urges for
a rethinking of scientiﬁc responsibility.
67In this
paper we present a method of reﬂection centred
around the concept ‘situated knowledges’,
8
emphasising that scientiﬁc knowledge depends on
where and by whom it is created. The method is in
exploratory use by the authors and their colleagues.
INCREASING MEDICAL DILEMMAS
Medical research promoting technological exami-
nations and treatments increasingly inﬂuences
general practice, creating and exacerbating conﬂicts
that can be difﬁcult to handle. Such technologies
imply improved prognoses for some, but at the
same time a growing number of risk diagnoses
narrow the limits for normality, causing stress,
dissatisfaction and ethical dilemmas in general
practitioner’s (GP) consultations.
1 91 0Guidelines,
incentives and targets promoting higher biomedical
standards may improve practice performance, but
tend to undermine the traditional strength of
general practicedthe focus on dialogue and rela-
tionship building.
11 12 Medicine seems to become
more technologically competent, but may at the
same time undervalue and dismiss the subjective
experiences of health and health resources.
13e15
Meanwhile, large numbers of people become ill
with complex diseases, such as chronic fatigue or
pain syndromes, which prevailing medical models
fail to understand.
41 5 e17 Not only patients, but
also doctors, may experience estrangement and
health impairment.
41 01 8
The conﬂicts outlined above have to be handled
by individual GPs, who become responsible for
interpreting science in a way that gives meaning
and hope to the patient.
11 16 Politicians are held
responsible for the broader social and ethical
assessment of medical science and the proper use of
economic resources.
4
While holding potential for improved practice,
the development outlined above also carries
inherent conﬂicts and dilemmas. Increased
demands to diagnose, prevent and cure increase the
costs.
18 Other side-effects have been discussed, for
example in terms of medicalisation, increased risk
of harming and growing inequalities in health
care.
13 18 19 GPs, working at the crossroads between
health care as a medical-technological and as
a humanistic enterprise, are particularly exposed to
conﬂicts arising from this development.
1 2 20 21
SCIENCE HAS DIRECTIONdAND CREATES
REALITY
A common metaphor for science is a cone of light
illuminating anincreasingpartofadarkmap.Inthis
image of scienceddelineated and dismantled by
Thomas Kuhn already in 1962dthe scientist has no
personal location, and is invisible, signifying objec-
tivity and scientiﬁc freedom.
5 Even if the scientist
always is a person with a social, cultural and polit-
ical identity, the scientiﬁc method is held to cleanse
science of ‘external’ or ‘non-epistemic’ values.
3
Thus, within this picture, scientiﬁc development is
both neutral (in terms of its objectivity), good in
itself (in terms of utility), and is expected to lead to
continuous social progress (Figure 1).
35The most
important consequence of this ‘functional myth’ is
that the scientiﬁc community cannot be held
responsible for what it simply ‘uncovers’.
38There-
fore, the scientist has no moral responsibility other
than that prescribed by norms of scientiﬁc honesty
and methodology and traditional medical ethics
such as embodied in the Declaration of Helsinki. We
believe this concept still holds sway within the
scientiﬁc community in spite of accumulating
research showing the complex entanglements of
economics, politics and culture with science.
346
Sponsors of research budgets have huge inﬂuence
on what is investigated, ie, on the direction of ‘the
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Research ethicscone of light’. By funding academic research, the pharmaceutical
industry has increased its impact on the design, evaluation and
reporting of medical research.
22 23 Among the most frequently
cited medical articles, the proportion funded by the industry has
increased during the past few decades.
22 The same industry
inﬂuences what is considered a disease, and which risks and
diseases should be subject to medical attention.
23 There is also
cultural inﬂuence. Most inﬂuential research has afﬁliation in
developed countries, above all the USA.
22 Research from the
west is attributed international signiﬁcance, whereas research
from non-industrial countries tends to be seen as local and
mainly illustrating the inﬂuence of culture.
24 The thinker,
Michel Foucault, introduced the concept ‘power-knowledge’,
rendering any analysis inadequate that treated power and
knowledge as separable phenomena.
25
The biomedical model and idea of speciﬁc aetiology, together
with a pressure on researchers to produce results that are readily
applicable, favour simpliﬁed explanations, followed by drug
therapy or other technologically based interventions.
4 26 Despite
the inability of this model to meet challenges raised by modern
research concerning causation, other directions are relatively
neglected, leading to the production of ‘more of the same
knowledge’ in many ﬁelds.
42 6This affects society’s under-
standing of what is counted as a disease or as ‘at-risk’ status, and
what is considered as cause, prevention and cure. It also affects
people’s perceptions of their own bodies and the world around
them.
1e49
Although mainstream medical science often presents itself as
value free, on a larger scale European political institutions are
beginning to question the detached view maintained by the
scientiﬁc community, and ask for broader input under the label
of governance of science. This applies particularly to ‘front line
sciences’ such as biotechnology and the nanosciences. For
example, the European Commission has produced a code of
conduct for responsible nanosciences and nanotechnologies, in
which the responsibility for sustainability, precaution and
meaningfulness of research has been laid on the research
community.
27
SITUATED KNOWLEDGESdA USEFUL CONCEPT?
The image of the scientist neutrally uncovering the secrets of
nature was described as the ‘God-trick’ by the biologist and
philosopher of science Donna Haraway, likening it to a gaze that
‘sees everything from nowhere’.
8 How then, can the self-
understanding of science be informed? What new concepts
could be used for this purpose? Haraway proposes the concept
of ‘situated knowledges’ against that of ‘objectivity’. ‘Situated
knowledges’ elucidate the limits and partiality of scientiﬁc
knowledge, arguing that knowledge must be interpreted in
relation to the context in which it is created. At the same time,
the concept recognises the strengths that knowledge created
from a particular perspective may possess. When scientists
declare and reﬂect on their ‘situatedness’, it allows different
ﬁndings and other forms of knowledge to be considered, opening
up more fundamental scientiﬁc and public debate.
6e8
METHOD FOR META-REFLECTION
As knowledge is situated, the context should be exposed to
structured exploration. A method designed for this purpose has
been further developed during seminars organised by the Philo-
sophical Polyclinic in Bergen, Norway (http://www.uib.no/isf/
ﬁlpol/). It also forms an integral part of the training component
for PhD students at several faculties at the University of Bergen,
as delivered by that university’s Centre for the Study of the
Sciences and Humanities. The method covers the entire research
process, divided into three parts. The initiation, design and
planning of a study are called ‘upstream elements’, and include
prerequisites, assumptions and previous knowledge. The
‘midstream elements’ concern the execution of the study.
The ﬁnal part, concerning the potential consequences of the
studydto individuals, health care and to societydis termed
‘downstream elements’. The idea is to elicit elements in each part
relevant to the ethical, social and political aspects of the research.
Upstream elements
Upstream elements include: Who funds the study, and why?
Why was it initiated? Who designed it, and how does this
inﬂuence the project? What understanding of illness, disease and
prevention shapes the project? To what extent does this depend
on available medical technology? What choices and thus, values,
are inherent in the deﬁnitions of a disease and the assessments of
risk, and how do they travel mid and downstream? Why is the
research question posed right now? Topicality, political signals,
strategic ventures of the research institution, funding possibili-
ties, power and prestige inherent in the topic, the need to
establish a new research area, or an existing database, may all be
relevant.
The study (midstream elements)
Internal review boards and ethics committees are mainly
concerned with the ethics of information and consent, as well as
the immediate risk to research subjects. When eliciting the
situatedness of the study execution, more questions need to be
asked. These include broader ethical questions, such as the
potential consequences of this approach for individuals, families,
the healthcare system and society. It is also important to ask
questions about situated and value-laden dimensions of the
Figure 1 A functional myth of medical scientiﬁc development.
Reproduced with permission of Marie Sterte.
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Research ethicschosen methodology. This is partly a question of validitydfor
instance whether a natural science, phenomenological or
hermeneutic, approach is most relevant to the research question.
However, it goes beyond that, acknowledging that each choice
of method in effect produces different knowledge and knowl-
edge gaps. Therefore, in our exercise, we ask: after performing
the study, what will not be known, which uncertainties will
remain, be sidelined, or even produced?
Downstream elements
Publicly ﬁnanced scientists are expected to publish and convey
their ﬁndings without considering the consequences, while
researchers ﬁnanced by the pharmaceutical industry may have
to adapt to the sponsoring companies’ decisions regarding
whether, when and in what form to publish the results.
23
Popular reporting of scientiﬁc ﬁndings may have unforeseen
consequences, such as the ‘worried well’, the questionable use of
healthcare resources and professional dilemmas for the doctor. In
the third phase of the exercise, potential downstream effects of
a project are discussed, such as the possible consequencesd
beneﬁts, costs, risks and opportunities to the individual, to the
healthcare system and to society. It should also be asked how
the project might inﬂuence the general and medical under-
standing of the condition or disease, and where this may direct
future focus regarding its prevention and treatment. Obviously,
the answers will be speculative and highly uncertain, but still
potentially important.
Implementation
The method may be tested out on an already published study.
Two persons, the author and a moderator, are needed.
Depending on available time, the audience reads the abstract
or the entire paper. The author presents the main results, and
time is allowed for clariﬁcation of uncertainties. Questions
regarding the internal validity of the study may be posed. The
researcher is then encouraged to reveal what he/she considers are
the most important validity limitations. After discussion in
small groups, the audience formulates what they regard to be
the main ﬁnding(s) and the key message(s). The moderator asks
for reformulations of such messages as punchline newspaper
headings. Then the concepts of ‘up-mid and downstream’
elements are presented by the moderator and discussed in
separate groups. Suggestions are noted on a white board. In the
subsequent discussion, the audience is encouraged to identify
up-mid and downstream elements and connections between
them.
Finally, the responsible researcher reviews the elements that
have been pointed out. For the exercise to work, the researcher
should defend his/her work without resorting to weakness or
withdrawal, but also avoid becoming defensive. The dialogue
must be based on mutual respect. The objective is to contribute
to greater understanding, not to political correctness.
This indeed follows from the perspective of ‘situated knowl-
edges’. Also the reﬂection contained in this paper, as well as the
exploratory method we have presented, have their own value-
ladenness and situatednessdin our case that of the experience of
the medical dilemmas described above (Box 1). The legitimacy of
our approach, as much as any other, depends on the context,
which is why we present it and hope for future reports of how it
works in different settings.
The method becomes more important when planning or
executing new research, because possible outcomes can be taken
into consideration before the research is undertaken or written
up. In such cases, the audience will be asked to formulate
possible future ﬁndings of the study. The model can be used
regardless of whether the research is qualitative or quantitative.
CONCLUSION
We consider the method suitable for the academic training of
faculty members and PhD candidates. In future, a summary
of such a process might be added to the research report or
paper, and if further taught and trained, could be required for
publication in medical journals.
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